These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36863566)

  • 61. Venous Thromboembolism Risk and Thromboprophylaxis Assessment in Surgical Patients Based on Caprini Risk Assessment Model.
    Tadesse TA; Kedir HM; Fentie AM; Abiye AA
    Risk Manag Healthc Policy; 2020; 13():2545-2552. PubMed ID: 33204195
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The cost-effectiveness and cost-utility analysis of the use of enoxaparin compared with heparin for venous thromboembolism prophylaxis in medical inpatients in Iran.
    Amirsadri M; Mousavi S; Karimipour A
    Daru; 2019 Dec; 27(2):627-634. PubMed ID: 31368091
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Association of pharmacologic thromboprophylaxis with clinically relevant bleeding and hospital-acquired anemia in medical inpatients: the risk stratification for hospital-acquired venous thromboembolism in medical patients study.
    Choffat D; Rossel JB; Aujesky D; Vollenweider P; Baumgartner C; Méan M
    J Thromb Haemost; 2024 Mar; 22(3):765-774. PubMed ID: 38072378
    [TBL] [Abstract][Full Text] [Related]  

  • 64. VTE Risk Profiles and Prophylaxis in Medical and Surgical Inpatients: The Identification of Chinese Hospitalized Patients' Risk Profile for Venous Thromboembolism (DissolVE-2)-A Cross-sectional Study.
    Zhai Z; Kan Q; Li W; Qin X; Qu J; Shi Y; Xu R; Xu Y; Zhang Z; Wang C;
    Chest; 2019 Jan; 155(1):114-122. PubMed ID: 30300652
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cost-effectiveness of thromboprophylaxis with intermittent pneumatic compression at cesarean delivery.
    Casele H; Grobman WA
    Obstet Gynecol; 2006 Sep; 108(3 Pt 1):535-40. PubMed ID: 16946212
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Thromboprophylaxis in Patients Admitted to the Surgical Ward: Clinical Audit.
    Abdalla YA; Kamil AM; Mohamed SAA; Mohamed AHA; Khalifa E; Mohamed MHA; Abdelgadir EEA; Dabora M; Awoda MSEME
    Vasc Health Risk Manag; 2023; 19():651-656. PubMed ID: 37767363
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period.
    Bain E; Wilson A; Tooher R; Gates S; Davis LJ; Middleton P
    Cochrane Database Syst Rev; 2014 Feb; (2):CD001689. PubMed ID: 24519568
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cost-effectiveness of prolonged thromboprophylaxis after cancer surgery.
    Bradley CT; Brasel KJ; Miller JJ; Pappas SG
    Ann Surg Oncol; 2010 Jan; 17(1):31-9. PubMed ID: 19707830
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The effect of physician educational intervention on venous thromboembolism pharmacological prophylaxis in medical inpatients from the respiratory department: a retrospective cohort study.
    Wang H; Pan Y; Chen T; Chen L; Lv H; Chen E; Qu J; Tang W; Xu W; Lu Y
    Ann Palliat Med; 2020 Nov; 9(6):3966-3975. PubMed ID: 33302659
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Venous thromboembolism prophylaxis in patients hospitalized in medical wards: A real life experience.
    Mahlab-Guri K; Otman MS; Replianski N; Rosenberg-Bezalel S; Rabinovich I; Sthoeger Z
    Medicine (Baltimore); 2020 Feb; 99(7):e19127. PubMed ID: 32049830
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines.
    Fontana P; Casini A; Robert-Ebadi H; Glauser F; Righini M; Blondon M
    Swiss Med Wkly; 2020 Jun; 150():w20301. PubMed ID: 32640479
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Stratification of venous thromboembolism risk in stroke patients by Caprini score.
    Zhu X; Zhang T; Zhou L; Yin X; Dong Q
    Ann Palliat Med; 2020 May; 9(3):631-636. PubMed ID: 32312069
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Inadequate venous thromboembolism risk stratification predicts venous thromboembolic events in surgical intensive care unit patients.
    Pannucci CJ; Obi A; Alvarez R; Abdullah N; Nackashi A; Hu HM; Bahl V; Henke PK
    J Am Coll Surg; 2014 May; 218(5):898-904. PubMed ID: 24680577
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cost-effectiveness analysis of low-dose direct oral anticoagulant (DOAC) for the prevention of cancer-associated thrombosis in the United States.
    Li A; Carlson JJ; Kuderer NM; Schaefer JK; Li S; Garcia DA; Khorana AA; Carrier M; Lyman GH
    Cancer; 2020 Apr; 126(8):1736-1748. PubMed ID: 31999844
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors.
    Artifoni M; Danic G; Gautier G; Gicquel P; Boutoille D; Raffi F; Néel A; Lecomte R
    J Thromb Thrombolysis; 2020 Jul; 50(1):211-216. PubMed ID: 32451823
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Venous thromboembolism risk and prophylaxis in hospitalized obstetric patients at a tertiary hospital in Accra, Ghana: A comparative cross-sectional study.
    Sefogah PE; Nuamah MA; Swarray-Deen A; Mumuni K; Onuzo CN; Seffah JD
    Int J Gynaecol Obstet; 2021 Jun; 153(3):514-519. PubMed ID: 33249576
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Optimizing pharmacologic thromboprophylaxis use in pediatric orthopedic surgical patients through implementation of a perioperative venous thromboembolism risk screening tool.
    MacNevin W; Padhye K; Alkhalife Y; Price V; El-Hawary R; Branchford BR; Stevens S; Kulkarni K
    Pediatr Blood Cancer; 2021 Feb; 68(2):e28803. PubMed ID: 33219749
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Value-of-information analysis to reduce decision uncertainty associated with the choice of thromboprophylaxis after total hip replacement in the Irish healthcare setting.
    McCullagh L; Walsh C; Barry M
    Pharmacoeconomics; 2012 Oct; 30(10):941-59. PubMed ID: 22667458
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Risk factors for inpatient venous thromboembolism despite thromboprophylaxis.
    Wang TF; Wong CA; Milligan PE; Thoelke MS; Woeltje KF; Gage BF
    Thromb Res; 2014 Jan; 133(1):25-9. PubMed ID: 24300584
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Incidence of Venous Thromboembolism and Benefits and Risks of Thromboprophylaxis After Cardiac Surgery: A Systematic Review and Meta-Analysis.
    Ho KM; Bham E; Pavey W
    J Am Heart Assoc; 2015 Oct; 4(10):e002652. PubMed ID: 26504150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.